Sotera Health [SHC] vs Qiagen N.V [QGEN] Detailed Stock Comparison
Sotera Health
NASDAQ
Loading...
Qiagen N.V
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Sotera Health wins in 3 metrics, Qiagen N.V wins in 16 metrics, with 0 ties. Qiagen N.V appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sotera Health | Qiagen N.V | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 181.89 | 27.51 | Qiagen N.V |
| Price-to-Book Ratio | 9.09 | 2.88 | Qiagen N.V |
| Debt-to-Equity Ratio | 460.02 | 42.31 | Qiagen N.V |
| PEG Ratio | 20.21 | -0.18 | Qiagen N.V |
| EV/EBITDA | 12.70 | 10.64 | Qiagen N.V |
| Profit Margin (TTM) | 2.14% | 18.30% | Qiagen N.V |
| Operating Margin (TTM) | 35.34% | 25.49% | Sotera Health |
| EBITDA Margin (TTM) | 35.34% | 25.49% | Sotera Health |
| Return on Equity | 5.14% | 10.81% | Qiagen N.V |
| Return on Assets (TTM) | 7.24% | 9.01% | Qiagen N.V |
| Free Cash Flow (TTM) | $45.09M | $502.31M | Qiagen N.V |
| 1-Year Return | 2.11% | 4.99% | Qiagen N.V |
| Price-to-Sales Ratio (TTM) | 4.13 | 4.94 | Sotera Health |
| Enterprise Value | $6.67B | $10.61B | Qiagen N.V |
| EV/Revenue Ratio | 5.93 | 5.20 | Qiagen N.V |
| Gross Profit Margin (TTM) | 56.61% | 62.65% | Qiagen N.V |
| Revenue per Share (TTM) | $4 | $9 | Qiagen N.V |
| Earnings per Share (Diluted) | $0.09 | $1.69 | Qiagen N.V |
| Beta (Stock Volatility) | 1.81 | 0.64 | Qiagen N.V |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sotera Health vs Qiagen N.V Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sotera Health | -2.97% | -3.15% | 41.67% | 30.13% | 36.82% | 17.33% |
| Qiagen N.V | 0.71% | -2.69% | -7.06% | 3.14% | 22.19% | 4.90% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sotera Health | 2.11% | 2.04% | -36.33% | -36.33% | -36.33% | -36.33% |
| Qiagen N.V | 4.99% | 1.17% | -5.75% | 68.41% | 137.78% | 226.35% |
Performance & Financial Health Analysis: Sotera Health vs Qiagen N.V
| Metric | SHC | QGEN |
|---|---|---|
| Market Information | ||
| Market Cap | $4.59B | $10.17B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 1,471,790 | 1,534,260 |
| 90 Day Avg. Volume | 1,533,057 | 1,488,693 |
| Last Close | $15.51 | $47.03 |
| 52 Week Range | $9.53 - $17.08 | $37.63 - $51.88 |
| % from 52W High | -9.22% | -9.35% |
| All-Time High | $30.38 (Mar 15, 2021) | $60.81 (Jul 17, 2000) |
| % from All-Time High | -48.95% | -22.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.08% |
| Quarterly Earnings Growth | -0.09% | 0.07% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.18% |
| Operating Margin (TTM) | 0.35% | 0.25% |
| Return on Equity (TTM) | 0.05% | 0.11% |
| Debt to Equity (MRQ) | 460.02 | 42.31 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.80 | $16.17 |
| Cash per Share (MRQ) | $1.17 | $4.40 |
| Operating Cash Flow (TTM) | $266.11M | $675.03M |
| Levered Free Cash Flow (TTM) | $218.81M | $683.15M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Sotera Health vs Qiagen N.V
| Metric | SHC | QGEN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 181.89 | 27.51 |
| Forward P/E | 20.21 | 20.31 |
| PEG Ratio | 20.21 | -0.18 |
| Price to Sales (TTM) | 4.13 | 4.94 |
| Price to Book (MRQ) | 9.09 | 2.88 |
| Market Capitalization | ||
| Market Capitalization | $4.59B | $10.17B |
| Enterprise Value | $6.67B | $10.61B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.93 | 5.20 |
| Enterprise to EBITDA | 12.70 | 10.64 |
| Risk & Other Metrics | ||
| Beta | 1.81 | 0.64 |
| Book Value per Share (MRQ) | $1.80 | $16.17 |
Financial Statements Comparison: Sotera Health vs Qiagen N.V
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SHC | QGEN |
|---|---|---|
| Revenue/Sales | $254.52M | $483.46M |
| Cost of Goods Sold | $119.09M | $174.78M |
| Gross Profit | $135.43M | $308.68M |
| Research & Development | N/A | $43.78M |
| Operating Income (EBIT) | $57.04M | $125.16M |
| EBITDA | $98.09M | $184.37M |
| Pre-Tax Income | $-14.82M | $119.55M |
| Income Tax | $-1.56M | $28.79M |
| Net Income (Profit) | $-13.26M | $90.76M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SHC | QGEN |
|---|---|---|
| Cash & Equivalents | $304.39M | $638.76M |
| Total Current Assets | $554.99M | $1.74B |
| Total Current Liabilities | $225.99M | $516.94M |
| Long-Term Debt | $2.32B | $1.35B |
| Total Shareholders Equity | $414.09M | $3.41B |
| Retained Earnings | $-623.30M | $2.50B |
| Property, Plant & Equipment | $1.07B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SHC | QGEN |
|---|---|---|
| Operating Cash Flow | $58.73M | $190.30M |
| Capital Expenditures | $-19.92M | $-43.90M |
| Free Cash Flow | $35.60M | $95.48M |
| Debt Repayment | $-3.77M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SHC | QGEN |
|---|---|---|
| Shares Short | 13.75M | 6.13M |
| Short Ratio | 9.40 | 4.04 |
| Short % of Float | 0.09% | 0.04% |
| Average Daily Volume (10 Day) | 1,471,790 | 1,534,260 |
| Average Daily Volume (90 Day) | 1,533,057 | 1,488,693 |
| Shares Outstanding | 283.47M | 216.12M |
| Float Shares | 134.03M | 214.89M |
| % Held by Insiders | 0.02% | 0.02% |
| % Held by Institutions | 0.96% | 0.87% |
Dividend Analysis & Yield Comparison: Sotera Health vs Qiagen N.V
| Metric | SHC | QGEN |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.44 |
| 3-Year Avg Dividend Yield | N/A | 3.03% |
| 3-Year Total Dividends | N/A | $1.32 |
| Ex-Dividend Date | N/A | Jan 30, 2024 |